BMS-193885

CAS No. 186185-03-5

BMS-193885( —— )

Catalog No. M26631 CAS No. 186185-03-5

BMS-193885 is a potent, selective, competitive, and brain penetrant neuropeptide Y1 receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 Get Quote
10MG 177 Get Quote
25MG 357 Get Quote
50MG 530 Get Quote
100MG 759 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BMS-193885
  • Note
    Research use only, not for human use.
  • Brief Description
    BMS-193885 is a potent, selective, competitive, and brain penetrant neuropeptide Y1 receptor antagonist.
  • Description
    BMS-193885 is a potent, selective, competitive, and brain penetrant neuropeptide Y1 receptor antagonist. With a Ki of 3.3 nM, and has an IC50 of 5.9 nM for hY1. It displays > 100, > 160, > 160 and > 160-fold selectivity over α1, hY2, hY4 and hY5 receptors, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186185-03-5
  • Formula Weight
    590.721
  • Molecular Formula
    C33H42N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (169.29 mM)
  • SMILES
    COC(=O)C1=C(C)NC(C)=C(C1c1cccc(NC(=O)NCCCN2CCC(CC2)c2cccc(OC)c2)c1)C(=O)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kutluay VM, et al. Cytotoxic phenylethanoid glycosides from Digitalis davisiana Heywood: Evaluation of structure activity relationships and chemotaxonomical significance of isolated compounds. Fitoterapia. 2019 Jun;135:90-98.
molnova catalog
related products
  • Sermorelin acetate

    Sermorelin acetate is a growth hormone-releasing hormone (GHRH) analog, is used as a diagnostic agent to assess growth hormone (GH) secretion.

  • Astegolimab

    Astegolimab (RG 6149) is a humanised IgG2 monoclonal antibody that targets the IL-33 receptor and inhibits IL-33 signalling. Astegolimab is used in the study of chronic obstructive pulmonary disease (COPD) and severe asthma in adults.

  • dl-Ibuterol hydrochl...

    dl-Ibuterol hydrochloride (Ibuterol HCl) has vasodilatory activity and can be used to study asthma and bronchospasm.